Close

Techno Trends

Medicago to develop new VLP vaccine candidate for rabies

Medicago, a biotechnology company, has completed initial studies towards the development of a new VLP vaccine candidate for rabies. The initial studies with rabies VLP vaccine demonstrated that two doses of one or four...

Oral therapy with Teriflunomide reduces relapses in multiple sclerosis

Sanofi and its subsidiary Genzyme has announced new data from the TEriflunomide multiple sclerosis oral (TEMSO) phase III trial showing once-daily oral teriflunomide significantly reduced annualized rates of relapses leading to hospitalization. New data also confirmed the safety profile...

CRANE ChemPharma Flow Solutions Launches New Interactive BioPharm Applications Module

CRANE ChemPharma Flow Solutions announced the launch of its new BioPharm applications module, an addition to its existing www.cranechempharma.com website.  The new interactive module can be also accessed directly at www.cranebiopharm.com, allowing an easier and faster link to...

Novel Hepatitis C Vaccine First Effective Way

French scientists have developed a novel hepatitis C vaccine that may offer the first effective way to prevent an infection that can cause chronic liver disease and cancer. There is currently no available vaccine for hepatitis C, though some...

Oracle Introduces Oracle Health Sciences InForm Global Trial Management 5.5

Oracle Health Sciences announced the availability of Oracle Health Sciences InForm Global Trial Management (GTM) 5.5, which includes powerful new functionality to help trial sponsors and clinical research organizations (CROs) improve clinical trial efficiency and increase the productivity of...

U.S. Southeast ‘Stroke Belt’ Also Shows Higher Rates of Cognitive Decline

People living in an area of the southeastern United States known as the "Stroke Belt" are also at greater risk for cognitive decline, or reduced brain function, than those living in other areas, new research suggests. ...

Omega-3 Fatty Acids Help Heart Patients With Stents

Combining omega-3 fatty acids with blood-thinning drugs may reduce the risk of heart attacks in patients who've had stents placed in their coronary arteries, a new European study suggests. While other research suggests that foods rich...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read